Clinical study on chronic subdural hematoma by traditional Chinese medicine.

Prospective clinical study on prevention of relapse after chronic subdural hematoma after traditional Chinese medicine. - CSDH kobe study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs051180131

Enrollment

300

Registered

2019-03-18

Start date

2017-04-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic subdural hematoma

Interventions

Arm Goreisan:As long as Kracie Goreisan-Ryo Extract Fine Granules (6.0 g / day) given 3 months after the operation. Arm Saireito:As long as Kracie Saireito Extract Fine Granules (8.1 g / day)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with chronic subdural hematoma. 2. Patient who is an initial case. 3. Patients who are over 20 years old.

Exclusion criteria

Exclusion criteria: 1.Patients who have difficulty in taking traditional Chinese medicine. 2.Patients who show marked decline in cognitive function and have difficulty in compliance with medication compliance (such as those with an MMSE score of 23 or less) 3. Asymptomatic and bilateral chronic subdural bloodline patients 4. Patients with severe renal dysfunction (creatinine clearance less than 30 mL / min etc.) 5.Patients who could not carry out prescribed surgery 6.Patients who have allergies of traditional Chinese medicine and herbal medicines (such as those with a history of hypokalemia) 7.Patients who are considered inappropriate for inclusion in research

Design outcomes

Primary

Measure	Time frame
Presence or absence of symptomatic recurrence within 3 months after operation.	—

Secondary

Measure	Time frame
Changes in AST,ALT,gamma-GTP	—

Contacts

Public ContactYasuhisa Yoshida

Eishoukai Yoshida Hospital.Cerebrovascular Research Institute

medical_office@yoshida-hp.or.jp+81-78-576-2773

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026